Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: implications for breast and ovarian cancer risk.

Molecular genetics and metabolism - 1 Jan 2000

Jernström Helena, Borg Ke, Olsson Håkan

Abstract excerpt

BRCA1 mutation carriers have up to 80% life-time risk of developing breast cancer and 20-40% risk of developing ovarian cancer. High LH levels have been linked to increased risks of both breast and ovarian cancers in some studies and it is unknown whether gonadotropin levels are associated with BRCA1 mutation status. The aim of the study was to explore whether gonadotropin levels were associated with BRCA1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to BRCA1 gene
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Carrier Screening

Share to Luteinizing Hormone

Share to Mutation

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 16084122
DOI: 10.1016/j.ymgme.2005.06.007

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: implications for breast and ovarian cancer risk.PMID 16084122Read ↗

Reduced reproductive potential in young healthy women with hereditary breast and/or ovarian cancer syndromeSemantic proximity Read ↗

Insulin-like growth factor-1 genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating insulin-like growth factor-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.Semantic proximity Read ↗

Distribution of age at natural menopause, age at menarche, menstrual cycle length, height and BMI in BRCA1 and BRCA2 pathogenic variant carriers and non-carriers: Results from EMBRACESemantic proximity Read ↗

Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.Semantic proximity Read ↗

Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group.Semantic proximity Read ↗

Prospective multicenter cohort study of estrogen and insulin-like growth factor system in BRCA mutation carriers.Semantic proximity Read ↗

Reproductive hormones, cancers, and conditions in relation to a common genetic variant of luteinizing hormone.Semantic proximity Read ↗

Baseline E(2) levels are higher in BRCA2 mutation carriers: a potential target for prevention?Semantic proximity Read ↗

Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

BRCA1 germline mutations may be associated with reduced ovarian reserve.Semantic proximity Read ↗

Antimüllerian hormone levels are lower in BRCA2 mutation carriers.Semantic proximity Read ↗

Premature menopause in patients with BRCA1 gene mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.